Section 122DA(1) in The Drugs and Cosmetics Rules, 1945
(1)No clinical trial for a new drug, whether for clinical investigation or any clinical experiment by any institution, shall be conducted except under, and in accordance with, the permission, in writing, of the licensing authority defined in clause (b) of rule 21.
